Skip to main content
. 2023 Jul 21;27:72. doi: 10.1186/s40824-023-00385-8

Table 2.

Representative example of peptide-based bioTPD

Pathway Adaptor Key sequences POI POI ligands Refs
Proteasome VHL MLAP(OH)YIPM

METAP2

ER

Fumagillo

Estradiol

[60]
LAP(OH)YI

AR

ER

CREPT

Dihydrotestosterone

Estradiol

VRALKQKYEELKKEKESLVDK

[100, 104]
ALAPYIP

Akt

FRS2α

PI3K

Tau

Recognition peptide for Akt2 (P-ser474) IENPQYFSDA

GPGGDYAAMGACPASEQGYEEMRA

YQYQDATADEQG

[109, 110, 114]
β-TRCP DRHDS(P)GLDS(P)M METAP2 Ovalicin [11]
KEAP1 LDPETGEYL Tau YQYQDATADEQG [118]
/ RRRG α-synuclein GVLYVGSKTR [136]
Lysosome

/

/

/

KFERQKILDQRFFE

MDFSGLSLIKLKKQ

cyclic RGDyK

DAPK1

α-synuclein

PD-L1

PD-L1

A fragment of the GluN2B subunit

A short peptide of β-synuclein

DKEMAATSAAIEDAVRRIEDMMNQ

BMS-8

[24]

[131]

[132]

Abbreviations: VHL, Von Hippel-Lindau; METAP2, Methionine aminopeptidase 2; ER, Estrogen receptor; AR, Androgen receptor; CREPT, Cell cycle-related and expression-elevated protein in tumor; Akt, Serine/threonine-protein kinase AKT; FRS2α, Factor receptor substrate 2α; PI3K, Phosphatidylinositol-3-kinase; Tau, microtubule-associated protein; α-synuclein, alpha-synuclein; DAPK1, Death associated protein kinase 1; PD-L1, programmed cell death ligand 1